Neoadjuvant Therapy in Biliary Adenocarcinoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Clinical Trials Related to Cholangiocarcinoma
Related studies linked through entity extraction aliases.
Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Hepatobiliary Tumors Tissue Samples Acquisition
- Status
- UNKNOWN
- Phase
- N/A
A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
- Status
- COMPLETED
- Phase
- PHASE1
Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
the Impact of Early Palliative Care on the Survival of Locally Advanced and / or Metastatic Cholangiocarcinoma Patients
- Status
- UNKNOWN
- Phase
- N/A
Advanced Endoscopy During COVID-19
- Status
- COMPLETED
- Phase
- N/A
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Cohort of Patients With Hepatocellular Carcinoma or Cholangiocarcinoma
- Status
- RECRUITING
- Phase
- N/A
A Novel Patient Engagement Platform Among Patients With Gastrointestinal Malignancies
- Status
- COMPLETED
- Phase
- NA
Neoadjuvant Gemcitabine Plus Cisplatin With or Without Durvalumab in Resectable Biliary Tract Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Pembrolizumab and Olaparib in Bile Duct Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1 In-vivo Biliary Study of KSP/QRH Heptapeptide Dimer
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Effect and Safety of PDT and RFA for Unresectable EHCC
- Status
- COMPLETED
- Phase
- NA
Pemigatinib in Treating Patients With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Including FGFR2 Rearrangement
- Status
- COMPLETED
- Phase
- PHASE2
Diagnosis, Treatment Status and Prognosis of Cholangiocarcinoma in China: a Multicenter, Two-way, Non-intervention Study
- Status
- UNKNOWN
- Phase
- N/A
A Study of E7090 in Participants With Unresectable Advanced or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor (FGFR) 2 Gene Fusion
- Status
- COMPLETED
- Phase
- PHASE2
Infigratinib for the Treatment of Advanced or Metastatic Solid Tumors in Patients With FGFR Gene Mutations
- Status
- COMPLETED
- Phase
- PHASE2